Intuitive Surgical, Inc. $ISRG Stock: Fisher Asset Management LLC Cuts Stake

Fisher Asset Management LLC lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.1% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,876,299 shares of the medical equipment provider’s stock after selling 42,541 shares during the quarter. Fisher Asset Management LLC owned about 1.12% of Intuitive Surgical worth $1,576,220,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Private Advisory Group LLC purchased a new stake in Intuitive Surgical in the 3rd quarter worth approximately $9,717,000. Legacy Trust boosted its holdings in Intuitive Surgical by 1.6% in the 3rd quarter. Legacy Trust now owns 12,032 shares of the medical equipment provider’s stock valued at $5,198,000 after purchasing an additional 192 shares during the period. Ariadne Wealth Management LP boosted its holdings in Intuitive Surgical by 18.1% in the 3rd quarter. Ariadne Wealth Management LP now owns 840 shares of the medical equipment provider’s stock valued at $341,000 after purchasing an additional 129 shares during the period. PBU The Pension Fund of Early Childhood & Youth Educators purchased a new position in shares of Intuitive Surgical during the 3rd quarter valued at $13,634,000. Finally, Three Bridge Wealth Advisors LLC grew its position in shares of Intuitive Surgical by 10.7% during the 3rd quarter. Three Bridge Wealth Advisors LLC now owns 629 shares of the medical equipment provider’s stock valued at $256,000 after purchasing an additional 61 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Activity at Intuitive Surgical

In related news, EVP Gary Loeb sold 400 shares of the stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $458.15, for a total value of $183,260.00. Following the transaction, the executive vice president owned 6,236 shares of the company’s stock, valued at $2,857,023.40. This represents a 6.03% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia L. Wadors sold 1,078 shares of the firm’s stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $443.80, for a total value of $478,416.40. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 39,456 shares of company stock worth $17,769,124 in the last three months. 0.60% of the stock is owned by insiders.

Intuitive Surgical Price Performance

ISRG stock opened at $439.89 on Friday. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88. The stock has a market cap of $152.48 billion, a PE ratio of 53.19, a P/E/G ratio of 3.10 and a beta of 1.45. The firm has a 50 day simple moving average of $416.12 and a two-hundred day simple moving average of $430.38.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. The firm had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The business’s revenue for the quarter was up 21.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.40 EPS. On average, research analysts expect that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, October 31st. Stifel Nicolaus reduced their target price on Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating for the company in a research report on Friday, July 17th. Weiss Ratings restated a “hold (c)” rating on shares of Intuitive Surgical in a research note on Friday, August 14th. JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $450.00 to $475.00 and gave the company an “overweight” rating in a report on Wednesday, October 21st. Finally, Oppenheimer reiterated an “outperform” rating and set a $500.00 price target on shares of Intuitive Surgical in a research report on Wednesday, October 21st. One research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $493.54.

Intuitive Surgical Company Profile

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.